Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Australian Fund Monitors Index returned 1.50% in July (+0.32% YTD) while ASX was up 4.46% (-7.75% YTD)

Tuesday, August 17, 2010
Opalesque Industry Update - According to Chris Gosselin, C.E.O. of Australian Fund Monitors Pty Ltd in Sydney, the current markets, whether they be equity or alternative, are proving to be testing times.

Although on a 12 month basis ASX 200 is still in positive territory, up 5.86%, over the 11 months period of September 2009 to the end of July 2010 the ASX 200 has gone nowhere. However that statistic obscures intra-month volatility which has tested fund managers, and long-suffering investors, with some wild swings.

In the past year the ASX 200 has made monthly gains or losses in excess of 5% on six occasions, with the 12% rally for August/September last year offset by the decline of a similar size from April to June 2010.

Index

July 2010

YTD

Last 12 Months

All Funds

1.50%

0.32%

8.12%

Equity Based

2.20%

-0.06%

10.43%

Non Equity Based

-0.27%

-0.04%

4.21%

ASX

4.46%

-7.75%

5.86%

S&P500

6.88%

-1.21%

11.56%

These are obviously not markets for trend followers. At the same time picking the timing of the market's next rise or fall has not been easy given the abrupt nature of directional changes.

Stock picking has been no easier, as has been shown in the past couple of weeks by the likes of Commonwealth Bank, Telstra, AWB and Leighton. This makes it interesting to look through managers' performance reports to see those which highlight positive performance from a particular earnings surprise or event, offset by another manager's negative performance from the same event.

So while it's been tough, it's been encouraging to see equity-based hedge funds at least make headway of close to 10% while the market has bounced up and down on the same spot. In addition year-to-date they have outperformed the ASX by close to 8%. That's not to say that there hasn't been significant monthly volatility within the hedge fund sector, and some significant under and over performance by particular funds.

15% of all funds in the AFM database turned in a negative performance over the past 12 months, whilst at the other end of the spectrum a similar percentage returned over 25%. Some managers that had previously provided stable results started to show that they were not infallible, whilst others continued to provide the consistency we had come to expect.

So while the markets are continuing to test fund managers, some managers' performances are continuing to test investors.

fundmonitors.com.au.


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its